Citations
Mayo Clinic
560 citation(s) found for "Nowakowski, K".
Incidence of Second Primary Malignancies in Lymphoma Survivors: A Prospective Cohort Study in the Modern Treatment Era
Mwangi, Raphael , Nowakowski, Grzegorz S. , Thompson, Carrie A. , Desai, Sanjal H. , Wang, Yucai , Farooq, Umar , Mou, Eric , Feldman, Andrew L. , Syrbu, Sergei , Slager, Susan L. , Maurer, Matthew J. , Kay, Neil E. , Habermann, Thomas M. , Link, Brian K. , Cerhan, James R.
Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 1934-1936
Outcomes with Immunochemotherapy Plus Radiation Versus Immunochemotherapy Alone in Stage I Diffuse Large B-Cell Lymphoma: A Retrospective Study
Ng, Wern Lynn , Bock, Allison M. , Wert, Yijin, Ng, Lay She , Nowakowski, Grzegorz S. , Kovalenko, Iuliia , Wang, Yucai
Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 3829-3830
Time to Complete Response within 24 Months As a Good Surrogate Marker of 8 Year-Progression Free Survival in Extranodal Marginal Zone Lymphoma
Conconi, Annarita , Nowakowski, Grzegorz S. , Thiéblemont, Catherine , Bommier, Côme , Zucca, Emanuele , Cerhan, James R. , Lambert, Jérôme
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 3583-3584
Clinical Outcomes in Patients with Mantle Cell Lymphoma Who Received Autologous Stem Cell Transplant in the Second Line Setting
Bock, Allison M. , Tawfiq, Reema, Poonsombudlert, Kittika , Maliske, Seth , Kabat, Brian, Gysbers, Brianna, Smith, Katherine E. , Inwards, David J. , Ansell, Stephen M. , Nowakowski, Grzegorz S. , Smith, Katherine E R , Gile, Jennifer , Larson, Melissa C. , Maurer, Matthew J. , Cerhan, James R. , Hwang, Steven R. , Paludo, Jonas , Habermann, Thomas M. , Ayyappan, Sabarish Ram , Witzig, Thomas E. , Farooq, Umar , Wang, Yucai
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 6517-6519
Evaluating the Impact of Lab-Based Eligibility Criteria By Race/Ethnicity in Frontline Clinical Trials for Diffuse Large B-Cell Lymphoma (DLBCL): A LEO Cohort Analysis
Khurana, Arushi , Mwangi, Raphael , McDonnell, Timothy J. , Riska, Shaun M., Lossos, Izidore S. , Flowers, Christopher R. , Nowakowski, Grzegorz S. , Nastoupil, Loretta J. , Reagan, Patrick Michael , Farooq, Umar , Romancik, Jason T. , Kahl, Brad S. , Martin, Peter, Witzig, Thomas E. , Cerhan, James R. , Maurer, Matthew J.
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 2056-2058
Molecular Landscape of Primary Refractory DLBCL
Bock, Allison M. , Wenzl, Kerstin , Stokes, Matthew E. , Hopper, Melissa A. , Dropik, Abigail R. , Sarangi, Vivekananda , Huang, C. Chris , King, Rebecca L. , Ansell, Stephen M. , Gandhi, Anita K. , Nowakowski, Grzegorz S. , Novak, Anne J. , Novak, Joseph P. , Krull, Jordan E. , Ortiz, Maria, Stong, Nicholas , Maurer, Matthew J. , Godby, Richard , Farooq, Umar , Wang, Yucai , Habermann, Thomas M. , Cerhan, James R.
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9221-9223
Phase 1b Trial of Cereblon-Modulating Agents Iberdomide and CC-99282 Plus R-CHOP in Previously Untreated Aggressive B-Cell Lymphoma
Yeh, Su‐Peng , Gkasiamis, Argyrios, Patah, Poliana, Patel, Arpankumar , Nowakowski, Grzegorz S. , Westin, Jason R. , Martı́n, Alejandro , Hoffmann, Marc Steven , Vassilakopoulos, Theodoros P. , Li, Ju
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9475-9477
Integrative Genomics Identifies a High-Risk Metabolic and TME Depleted Signature That Predicts Early Clinical Failure in DLBCL
Wenzl, Kerstin , Stokes, Matthew E. , Khan, Sana, Hopper, Melissa A. , Dropik, Abigail R. , Sarangi, Vivekananda , Mwangi, Raphael , Huang, C. Chris , Asmann, Yan W. , Ansell, Stephen M. , King, Rebecca L. , Nowakowski, Grzegorz S. , Gandhi, Anita K. , Novak, Anne J. , Novak, Joseph P. , Krull, Jordan E. , Ortiz, Maria, Stong, Nicholas , Maurer, Matthew J. , Rimsza, Lisa M. , Link, Brian K. , Slager, Susan L. , Mondello, Patrizia , Morin, Ryan D , Habermann, Thomas M. , Feldman, Andrew L. , Cerhan, James R.
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 1742-1744
Secreted Sars-Cov-2 Encoded ORF8 Protein Stimulates Pro-Inflammatory Cytokines and Predicts Severe Clinical Outcome
Wu, Xiaosheng , Ruan, Gordon , Witter, Taylor L. , Gwin, Kimberly, Nowakowski, Kevin E., Abeykoon, Jithma P. , Tang, Xinyi , Yu, Yue , Dasari, Surendra , Ansell, Stephen M. , Schellenberg, Matthew J. , Manske, Michelle K. , Tang, Xinyi, Paludo, Jonas , Badley, Andrew D. , Witzig, Thomas E.
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 42-43
Frontmind: A Phase III, Multicenter, Randomized, Double-Blind Study of Tafasitamab + Lenalidomide + R-CHOP Versus R-CHOP Alone for Newly Diagnosed High-Intermediate and High-Risk Diffuse Large B-Cell Lymphoma
Nowakowski, Grzegorz S. , Burke, John M. , Waldron-Lynch, Maeve, Wagner, Steve, Pachori, Alok, Lenz, Georg , Vitolo, Umberto , Fox, Christopher P. , Trněný, Marek , Chiappella, Annalisa
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 6618-6620